From: TES functions as a Mena-dependent tumor suppressor in gastric cancer carcinogenesis and metastasis
Characteristic | High Mena expression group (cases) | Low Mena expression group (cases) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Total (cases) | High TES expression | Low TES expression | χ2 | P value | Total (cases) | High TES expression | Low TES expression | χ2 | P value | |
Tumor infiltration | 8.141 | 0.005 | Â | Â | Â | 1.486 | 0.854 | |||
T1–T2 | 19 | 14 | 5 |  |  | 32 | 16 | 16 |  |  |
T3–T4 | 80 | 30 | 50 |  |  | 41 | 18 | 23 |  |  |
Local lymph node metastasis | 10.106 | 0.003 | Â | Â | Â | 0.269 | 0.643 | |||
N0 | 27 | 19 | 8 | Â | Â | 32 | 16 | 16 | Â | Â |
N1–N3 | 72 | 25 | 47 |  |  | 41 | 18 | 23 |  |  |
Distant metastasis | 3.457 | 0.105 | Â | Â | Â | 0.333 | 0.725 | |||
M0 | 88 | 42 | 46 | Â | Â | 64 | 29 | 35 | Â | Â |
M1 | 11 | 2 | 9 | Â | Â | 9 | 5 | 4 | Â | Â |
TNM stage | 13.109 | 0.003 | Â | Â | Â | 2.560 | 0.489 | |||
0–I | 9 | 7 | 2 |  |  | 21 | 9 | 12 |  |  |
II | 40 | 23 | 17 | Â | Â | 29 | 13 | 16 | Â | Â |
III | 38 | 12 | 26 | Â | Â | 12 | 8 | 4 | Â | Â |
IV | 12 | 2 | 10 | Â | Â | 11 | 4 | 7 | Â | Â |